First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

528 Reviews

Credit Rating - DRUG TESTING PRODUCTS LTD

ANALYSIS
Credit Risk Update: ACCOUNTS DUE FLAG: DRUG TESTING PRODUCTS LTD, 63 Cambridge Road, Girton, Cambridge, CB3 0PN. The legal status is a Private Limited Company and the current status at the registry of companies is Dissolved. The last filed accounts are dated 31 March 2015. The company was incorporated on 2 May 2002.

The accounts next due date is 31 December 2016. There is 1 mortgage, which is satisfied

The above was based on public record information as at 1 January 2025 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 04430240
Date Incorporated: 2 May 2002
Date Latest Accounts: 31 March 2015
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: DRUG TESTING PROGRAM MANAGEMENT LTD
Registered Number: 04430240
Annual Return: 2 May 2016
Registered Office: 63 Cambridge Road, Girton, Cambridge, CB3 0PN
SIC Code and Operations: 47749
SECURED CREDITORS
Number of Mortgages 1
Satisfied Mortgages 1
Part Satisfied Mortgages 0
Unsatisfied Mortgages 0
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

DRUG TESTING PRODUCTS LTD

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 11 January 2025 Copyright © 2025 First Report Ltd


Recent Searches

Reg No. Reg Name Status
09535369 DRUG WASTE INTERNATIONAL LIMITED Active - Proposal to Strike off
CE000105 DRUG WATCH FOUNDATION Active
14451106 DRUGA CONSTRUCT LTD Active - Proposal to Strike off
15035881 DRUGA IONEL CONSTRUCT LIMITED Active
11783585 DRUGA TATTOOS LIMITED Active - Proposal to Strike off

In using this service you agree to the Terms and Conditions

© 2025 First Report Ltd